Company Filing History:
Years Active: 2022
Title: Shanshan Yan: Innovator in LATS Inhibition
Introduction
Shanshan Yan is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceutical compounds. His work primarily focuses on the development of innovative compounds that serve as inhibitors for specific biological pathways.
Latest Patents
Shanshan Yan holds a patent for "6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors." This invention relates to 6-6 fused bicyclic heteroaryl compounds of the Formula A2 or A1, which are utilized as LATS inhibitors, along with their salts, stereoisomers, or pharmaceutical compositions. The patent also outlines methods for LATS inhibition in cell populations using these compounds, as well as their therapeutic applications in treating various diseases and disorders.
Career Highlights
Shanshan Yan is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop groundbreaking pharmaceutical solutions that address critical health challenges.
Collaborations
Shanshan has collaborated with several professionals in his field, including Dirk Behnke and Frada Berenshteyn, who contribute to the innovative environment at Novartis AG.
Conclusion
Shanshan Yan's contributions to the field of pharmaceutical innovation, particularly through his patent on LATS inhibitors, highlight his role as a key inventor in advancing medical science. His work continues to pave the way for new therapeutic options in healthcare.